---
layout: page-fullwidth
title: "Publications"
subheadline: ""
teaser: "(Peer-reviewed journal articles)"
permalink: "/publications/"
---
`Asterisks * indicate joint first authors`


Linking early-life bilingualism and cognitive advantage in older adulthood
:   Ballarini, T., Kuhn, E., Röske, S., … <u>Kobeleva, X.</u>, … & DELCODE Study Group (2023)<br><b>Neurobiology of Aging</b>, 124, 18-28. [DOI](https://doi.org/10.1016/j.neurobiolaging.2022.12.005)

Jessen, F., Wolfsgruber, S., Kleineindam, L., … <u>Kobeleva, X.</u>, … & Düzel, E. (2023).
:   Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers.<br><b>Alzheimer's & Dementia</b>, 19(2), 487-497. [DOI](https://doi.org/10.1002/alz.12674)

Kleineidam, L., Wolfsgruber, S., Weyrauch, A.-S., … <u>Kobeleva, X.</u>, … & Wagner, M. (2022).
:   Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve.<br><b>Frontiers in Psychology</b>, 13, 957308. [DOI](https://doi.org/10.3389/fpsyg.2022.957308)

Pohl, E.`*`, Upadhuay, N.`*`, <u>Kobeleva, X.</u>`*`, … & Boecker, H. (2022). 
:   Coherent structural and functional network changes after Nucleus Ventralis Intermedius lesion in Essential Tremor.<br><b>Movement Disorders</b>, 37(9), 1924-1929. [DOI](https://doi.org/10.1002/mds.29130)

<u>Kobeleva, X.</u>, Varoquaux, G., Dagher A., Adhikari, M., Grefkes, C., Gilson, M. (2022).
:   Advancing brain network models to reconcile functional neuroimaging and clinical research.<br><b>NeuroImage Clinical</b>, 36, 103262. [DOI](https://doi.org/10.1016/j.nicl.2022.103262)

Cordts, E., Oender, D., Traschütz, A., <u>Kobeleva, X.</u>, … & Deschauer, M. (2022).
:   Adult-Onset Neurodegeneration in Nucleotide Excision Repair Disorders (NERD<sub>ND</sub>): Time to Move Beyond the Skin.<br><b>Movement Disorders</b>, 37(8), 1707-1718. [DOI](https://doi.org/10.1002/mds.29071)

<u>Kobeleva, X.</u>, López-González, A., Kringelbach, M., & Deco, G. (2021).
:   Revealing the relevant spatiotemporal scale underlying whole-brain dynamics.<br><b>Frontiers of Neuroscience</b>, 15, 715861. [DOI](https://doi.org/10.3389/fnins.2021.715861)

<u>Kobeleva, X.</u>, Machts, J., Veit, M., Vielhaber, S., Petri, S., & Schoenfeld, M.A. (2021).
:   Brain activity is contingent on neuropsychological function in an fMRI study of Verbal Working Memory in Amyotrophic Lateral Sclerosis.<br><b>European Journal of Neurology</b>, 28(89), 3051-3060. [DOI](https://doi.org/10.1111/ene.14957)

Fu, T., <u>Kobeleva, X.</u>, Bronzlik, P., Nösel, P., Dadak, M., Lanfermann, H., Petri, S., Ding X. (2021).
:   Clinically applicable quantitative magnetic resonance morphologic measurements of grey matter changes in the human brain.<br><b>Brain Sciences</b>, 11(1), 55. [DOI](https://doi.org/10.3390/brainsci11010055)

Sannemann, L., Schild, A.-K., … <u>Kobeleva, X.</u>, … & Jessen, F. (2020).
:   Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers—results from the DELCODE study.<br><b>Alzheimer's Research & Therapy</b>, 12(1), 1-11. [DOI](https://doi.org/10.1186/s13195-020-00701-7)

Wolfsgruber, S., Kleineidam L., … & DELCODE Study Group (<u>Kobeleva, X.</b> part of DECLODE Study Group) (2020).
:   Minor neuropsychological deficits in patients with subjective cognitive decline.<br><b>Neurology</b>, 95(9), e1134-e1143. [DOI](https://doi.org/10.1212/WNL.0000000000010142)

Husain, R.A., Grimmel, A., … <u>Kobeleva, X.</u>, … Haack, T.B. (2020).
:   Bi-allelic HPDL variants cause a neurodegenerative disease ranging from Neonatal Encephalopathy to Adolescent-Onset Spastic Paraplegia.<br><b>American Journal of Human Genetics</b>, 107(2), 364-373. [DOI](https://doi.org/10.1016/j.ajhg.2020.06.015)

Fard, M. A. F., Rebelo, A. P., Buglo, E., Nemati, H., Dastsooz, H., Gehweiler, I., … <u>Kobeleva, X.</u>, … & Cortese, A. (2019).
:   Truncating Mutations in UBAP1 Cause Hereditary Spastic Paraplegia.<br><b>The American Journal of Human Genetics</b>, 104(4), 767-773. [DOI](https://doi.org/10.1016/j.ajhg.2019.03.001)

Ludolph, A. C., Schuster, … & RAS-ALS Study Group (<U>Kobeleva, X.</u> part of RAS-ALS Study Group) (2018).
:   Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.<br><b>The Lancet Neurology</b>, 17(8), 681-688. [DOI](https://doi.org/10.1016/S1474-4422(18)30176-5)

Westeneng, H. J., Debray, T. P., Visser, A. E., van Eijk, R. P., Rooney, J. P., Calvo, A., … <u>Kobeleva, X.</u>, … & van den Berg, L. H. (2018).
:   Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.<br><b>The Lancet Neurology</b>, 17(5), 423-433. [DOI](https://doi.org/10.1016/S1474-4422(18)30089-9)

Peraza, L. R., Cromarty, R., <u>Kobeleva, X.</u>, Firbank, M. J., Killen, A., Graziadio, S., … & Taylor, J.-P. (2018).
:   Electroencephalographic derived network differences in Lewy body dementia compared to Alzheimer’s disease patients.<br><b>Scientific Reports</b>, 8(1), 4637. [DOI](https://doi.org/10.1038/s41598-018-22984-5)

<u>Kobeleva, X.</u>`*`, Firbank, M.`*`, Peraza, L., Gallagher, P., Thomas, A., Burn, D. J., … & Taylor, J. P. (2017).
:   Divergent functional connectivity during attentional processing in Lewy body dementia and Alzheimer's disease.<br><b>Cortex</b>, 92, 8-18. [DOI](https://doi.org/10.1016/j.cortex.2017.02.016)

Meininger, V., Genge, A., … & NOG112264 Study Group (<u>Kobeleva, X.</u> part of NOG112264 Study Group) (2017).
:   Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.<br><b>The Lancet Neurology</b>, 16(3), 208-216. [DOI](https://doi.org/10.1016/S1474-4422(16)30399-4)

Vellage, A. K., Veit, M., <u>Kobeleva, X.</u>, Petri, S., Vielhaber, S., & Müller, N. G. (2016).
:   Working memory network changes in ALS: an fMRI Study.<br><b>Frontiers in Neuroscience</b>, 10, 158. [DOI](https://doi.org/10.3389/fnins.2016.00158)

Firbank, M.`*`, <u>Kobeleva, X.</u>`*`, Cherry, G., Killen, A., Gallagher, P., Burn, D. J., … & Taylor, J. P. (2016).
:   Neural correlates of attention‐executive dysfunction in lewy body dementia and Alzheimer's disease.<br><b>Human Brain Mapping</b>, 37(3), 1254-1270. [DOI](https://doi.org/10.1002/hbm.23100)

Funke, A., Grehl, T., Großkreutz, J., Münch, C., Walter, B., Kettemann, D., … <u>Kobeleva, X.</u>, … & Meyer, T. (2015).
:   Hilfsmittelversorgung bei der amyotrophen Lateralsklerose.<br>[German] <b>Der Nervenarzt</b>, 86(8), 1007-1017. [DOI](https://doi.org/10.1007/s00115-015-4398-2)

<u>Kobeleva, X.</u>, Seidel, E. M., Kohler, C., Schneider, F., Habel, U., & Derntl, B. (2014).
:   Dissociation of explicit and implicit measures of the behavioral inhibition and activation system in borderline personality disorder.<br><b>Psychiatry Research</b>, 218(1-2), 134-142. [DOI](https://doi.org/10.1016/j.psychres.2014.04.027)

<u>Kobeleva, X.</u>, Wegner, F., Brunotte, I., Dadak, M., Dengler, R., & Stangel, M. (2014).
:   Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab.<br><b>Journal of Neuroinflammation</b>, 11(1), 19. [DOI](https://doi.org/10.1186/1742-2094-11-19)

<u>Kobeleva, X.</u>, & Petri, S. (2013).
:   Barriers to novel therapeutics in amyotrophic lateral sclerosis.<br><b>Neurodegenerative Disease Management<b/>, 3(6), 525-537. [DOI](https://doi.org/10.2217/nmt.13.66)
